154 related articles for article (PubMed ID: 34313623)
1. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E
Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study.
Dilaghi E; Dottori L; Pivetta G; Dalla Bella M; Esposito G; Ligato I; Pilozzi E; Annibale B; Lahner E
Am J Gastroenterol; 2023 Dec; 118(12):2157-2165. PubMed ID: 37207305
[TBL] [Abstract][Full Text] [Related]
3. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
4. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
5. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area.
Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up.
Zhang L; Liu Y; You P; Feng G
Scand J Gastroenterol; 2018; 53(7):843-848. PubMed ID: 29911441
[TBL] [Abstract][Full Text] [Related]
8. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
9. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
10. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia.
Quach DT; Le HM; Hiyama T; Nguyen OT; Nguyen TS; Uemura N
Helicobacter; 2013 Apr; 18(2):151-7. PubMed ID: 23167960
[TBL] [Abstract][Full Text] [Related]
11. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; Lopes C; da Costa-Pereira A; Guilherme M; Barbosa J; Lomba-Viana H; Silva R; Moreira-Dias L
J Clin Pathol; 2004 Feb; 57(2):177-82. PubMed ID: 14747445
[TBL] [Abstract][Full Text] [Related]
12. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
13. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
14. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
15. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
[TBL] [Abstract][Full Text] [Related]
16. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study.
Bas B; Dinc B
Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
20. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
